ONCSM.E — Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
TRY4.16bn
Enterprise Value
TRY4.16bn
Revenue
TRY240.51m

Annual balance sheet for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	6.17	8.42	5.77	19.3	58.5
Net Total Accounts Receivable
Net Total Receivables	13.3	23.4	34.3	78.5	55.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	24.2	41.9	85.4	199	195
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	75.9	86.5	39.3	137	118
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	101	132	130	350	338
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24.3	36	44.1	96.3	90.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	45.9	57.9	50.8	126	107
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	55.5	74.3	78.8	224	232
Total Liabilities & Shareholders' Equity	101	132	130	350	338
Total Common Shares Outstanding